
Interpace Biosciences IDXG
$ 1.8
-5.26%
Quarterly report 2026-Q1
added 05-12-2026
Interpace Biosciences ROCE Ratio 2011-2026 | IDXG
Annual ROCE Ratio Interpace Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.26 | -365.72 | -7.12 | 6.23 | 14.94 | -96.75 | -39.1 | -18.39 | -18.99 | -43.74 | -61.01 | -12.89 | -11.36 | -2.4 | -6.99 | -9.93 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.26 | -365.72 | -40.93 |
Quarterly ROCE Ratio Interpace Biosciences
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -655.04 | -664.46 | -285.27 | -325.88 | -11.62 | -11.6 | -8.38 | -4.43 | -2.39 | -1.12 | 2.84 | 6.38 | 7.46 | 12.18 | 19.04 | 26.64 | 24.44 | 45.09 | 60.21 | 78.0 | 66.4 | 225.65 | 324.39 | 1712.95 | 1687.04 | 1680.5 | 1516.15 | 1388.05 | -20.35 | -27.36 | -28.97 | -15.5 | -6.78 | -106.12 | -124.85 | -150.55 | -158.93 | -190.43 | -126.5 | -132.64 | -98.79 | -109.73 | -81.85 | -47.85 | -15.98 | -21.43 | -12.74 | -3.13 | -1.72 | -3.51 | 1.18 | 2.91 | -3.07 | -2.78 | -2.58 | -3.89 | -3.37 | 0.29 | -1.59 | -2.06 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1712.95 | -664.46 | 90.21 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 18.56 | 10.74 % | $ 196 M | ||
|
Agilent Technologies
A
|
25.0 | - | - | $ 34.4 B | ||
|
Castle Biosciences
CSTL
|
-9.09 | $ 18.88 | 4.02 % | $ 547 M | ||
|
Fulgent Genetics
FLGT
|
-6.52 | $ 16.19 | 1.44 % | $ 490 M | ||
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
-10.16 | $ 20.49 | -0.58 % | $ 1.09 B | ||
|
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | ||
|
Medpace Holdings
MEDP
|
116.53 | $ 419.17 | -1.08 % | $ 12.1 B | ||
|
Check-Cap Ltd.
CHEK
|
-69.04 | - | - | $ 9.42 M | ||
|
Lantheus Holdings
LNTH
|
28.52 | - | - | $ 6.5 B | ||
|
Mettler-Toledo International
MTD
|
35.8 | $ 1 041.91 | 1.75 % | $ 21.5 B | ||
|
Myriad Genetics
MYGN
|
-105.22 | $ 3.62 | -2.95 % | $ 335 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
-236.6 | $ 1.63 | 1.87 % | $ 2.17 M | ||
|
NeoGenomics
NEO
|
-9.11 | $ 8.36 | 1.21 % | $ 1.07 B | ||
|
National Research Corporation
NRC
|
161.47 | $ 18.93 | 1.39 % | $ 424 M | ||
|
Natera
NTRA
|
-76.66 | $ 196.91 | 0.81 % | $ 19.4 B | ||
|
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
0.8 | $ 159.12 | -2.29 % | $ 7.89 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | ||
|
Koninklijke Philips N.V.
PHG
|
7.33 | $ 25.5 | -0.51 % | $ 24.2 B | ||
|
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | ||
|
Personalis
PSNL
|
-33.71 | $ 6.71 | 5.01 % | $ 599 M | ||
|
Guardant Health
GH
|
440.3 | $ 98.66 | 0.19 % | $ 12.4 B | ||
|
Senseonics Holdings
SENS
|
-111.94 | $ 5.82 | 5.82 % | $ 243 M | ||
|
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 117.09 | -0.25 % | $ 9.66 B | ||
|
Illumina
ILMN
|
-35.1 | $ 143.24 | -1.21 % | $ 22.8 B | ||
|
Soleno Therapeutics
SLNO
|
2.09 | $ 52.99 | 0.08 % | $ 2.69 B | ||
|
Trinity Biotech plc
TRIB
|
-29.73 | $ 0.58 | -1.08 % | $ 208 M | ||
|
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
-28.81 | $ 52.95 | -2.65 % | $ 3.17 B | ||
|
Biomerica
BMRA
|
-125.14 | $ 2.41 | 7.11 % | $ 5.54 M | ||
|
Thermo Fisher Scientific
TMO
|
14.5 | $ 448.21 | 0.49 % | $ 169 B | ||
|
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 254.02 | -0.16 % | $ 21.1 B | ||
|
Waters Corporation
WAT
|
7.05 | $ 333.21 | -0.51 % | $ 19.8 B | ||
|
Celcuity
CELC
|
-171.24 | $ 134.72 | 8.23 % | $ 6.3 B | ||
|
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-51.22 | $ 8.43 | -2.99 % | $ 1.83 B |